Allogeneic Mesenchymal Stem Cell Therapy with Laromestrocel in Mild Alzheimer’s Disease

ERG Holding Company LLC published this content on April 15, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 13, 2026 at 12:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]